Finanzen von Kenvue Inc (KVUE)KVUEKenvue Inc

Kenvue Inc. (KVUE) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Face and Body Care, accounting for 18.0% of total sales, equivalent to $711.90M. Other significant revenue streams include Other Self Care and Cough, Cold and Allergy. Understanding this composition is critical for investors evaluating how KVUE navigates market cycles within the Personal Products industry.

Evaluating the bottom line, Kenvue Inc. maintains a gross margin of 58.58%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 19.54%, while the net margin is 11.53%. These profitability ratios, combined with a Return on Equity (ROE) of 15.58%, provide a clear picture of how effectively KVUE converts its operational activities into shareholder value.

In the context of the broader market, KVUE competes directly with industry leaders such as EL and KMB. With a market capitalization of $34.15B, it holds a significant position in the sector. When comparing efficiency, KVUE's gross margin of 58.58% stands against EL's 75.60% and KMB's 38.79%. Such benchmarking helps identify whether Kenvue Inc. is trading at a premium or discount relative to its financial performance.

Kenvue has shown consistent revenue growth, with Q2 2026 revenue reported at $3.96 billion, up from $3.83 billion in Q2 2025. The gross margin is strong at 58.58%, indicating efficient cost management.